350 related articles for article (PubMed ID: 19958580)
21. Aerosol drug delivery: developments in device design and clinical use.
Dolovich MB; Dhand R
Lancet; 2011 Mar; 377(9770):1032-45. PubMed ID: 21036392
[TBL] [Abstract][Full Text] [Related]
22. Particle sizing of pharmaceutical aerosols via direct imaging of particle settling velocities.
Fishler R; Verhoeven F; de Kruijf W; Sznitman J
Eur J Pharm Sci; 2018 Feb; 113():152-158. PubMed ID: 28821437
[TBL] [Abstract][Full Text] [Related]
23. The expanding role of aerosols in systemic drug delivery, gene therapy, and vaccination.
Laube BL
Respir Care; 2005 Sep; 50(9):1161-76. PubMed ID: 16122400
[TBL] [Abstract][Full Text] [Related]
24. Particle size and charge distribution analysis of pharmaceutical aerosols generated by inhalers.
Saini D; Biris AS; Srirama PK; Mazumder MK
Pharm Dev Technol; 2007; 12(1):35-41. PubMed ID: 17484142
[TBL] [Abstract][Full Text] [Related]
25. Development of budesonide nanocluster dry powder aerosols: processing.
El-Gendy N; Selvam P; Soni P; Berkland C
J Pharm Sci; 2012 Sep; 101(9):3425-33. PubMed ID: 22539360
[TBL] [Abstract][Full Text] [Related]
26. In vivo-in vitro correlations: predicting pulmonary drug deposition from pharmaceutical aerosols.
Byron PR; Hindle M; Lange CF; Longest PW; McRobbie D; Oldham MJ; Olsson B; Thiel CG; Wachtel H; Finlay WH
J Aerosol Med Pulm Drug Deliv; 2010 Dec; 23 Suppl 2():S59-69. PubMed ID: 21133801
[TBL] [Abstract][Full Text] [Related]
27. A review of factors affecting electrostatic charging of pharmaceuticals and adhesive mixtures for inhalation.
Kaialy W
Int J Pharm; 2016 Apr; 503(1-2):262-76. PubMed ID: 26836710
[TBL] [Abstract][Full Text] [Related]
28. Electrostatic charge characteristics of jet nebulized aerosols.
Kwok PC; Trietsch SJ; Kumon M; Chan HK
J Aerosol Med Pulm Drug Deliv; 2010 Jun; 23(3):149-59. PubMed ID: 20500092
[TBL] [Abstract][Full Text] [Related]
29. Pulmonary and Regional Deposition of Nebulized and Dry Powder Aerosols in Ferrets.
Kuehl PJ; Chand R; McDonald JD; Hava DL; DeHaan WH
AAPS PharmSciTech; 2019 Jul; 20(6):242. PubMed ID: 31264190
[TBL] [Abstract][Full Text] [Related]
30. Fundamental effects of particle morphology on lung delivery: predictions of Stokes' law and the particular relevance to dry powder inhaler formulation and development.
Crowder TM; Rosati JA; Schroeter JD; Hickey AJ; Martonen TB
Pharm Res; 2002 Mar; 19(3):239-45. PubMed ID: 11934228
[TBL] [Abstract][Full Text] [Related]
31. [Aerosol therapy].
Wildhaber JH
Schweiz Med Wochenschr; 1998 Aug; 128(33):1223-8. PubMed ID: 9757487
[TBL] [Abstract][Full Text] [Related]
32. Novel alternative methods for the delivery of drugs for the treatment of asthma.
Chan HK; Chew NY
Adv Drug Deliv Rev; 2003 Jul; 55(7):793-805. PubMed ID: 12842601
[TBL] [Abstract][Full Text] [Related]
33. Mechanisms of pharmaceutical aerosol deposition in the respiratory tract.
Cheng YS
AAPS PharmSciTech; 2014 Jun; 15(3):630-40. PubMed ID: 24563174
[TBL] [Abstract][Full Text] [Related]
34. The PulmoSphere™ platform for pulmonary drug delivery.
Weers J; Tarara T
Ther Deliv; 2014 Mar; 5(3):277-95. PubMed ID: 24592954
[TBL] [Abstract][Full Text] [Related]
35. Physical characterization of component particles included in dry powder inhalers. I. Strategy review and static characteristics.
Hickey AJ; Mansour HM; Telko MJ; Xu Z; Smyth HD; Mulder T; McLean R; Langridge J; Papadopoulos D
J Pharm Sci; 2007 May; 96(5):1282-301. PubMed ID: 17455324
[TBL] [Abstract][Full Text] [Related]
36. The History of Therapeutic Aerosols: A Chronological Review.
Stein SW; Thiel CG
J Aerosol Med Pulm Drug Deliv; 2017 Feb; 30(1):20-41. PubMed ID: 27748638
[TBL] [Abstract][Full Text] [Related]
37. A new Pharmaceutical Aerosol Deposition Device on Cell Cultures (PADDOCC) to evaluate pulmonary drug absorption for metered dose dry powder formulations.
Hein S; Bur M; Schaefer UF; Lehr CM
Eur J Pharm Biopharm; 2011 Jan; 77(1):132-8. PubMed ID: 20951200
[TBL] [Abstract][Full Text] [Related]
38. Air classifier technology (ACT) in dry powder inhalation Part 4. Performance of air classifier technology in the Novolizer multi-dose dry powder inhaler.
de Boer AH; Hagedoorn P; Gjaltema D; Goede J; Frijlink HW
Int J Pharm; 2006 Mar; 310(1-2):81-9. PubMed ID: 16442246
[TBL] [Abstract][Full Text] [Related]
39. The electrospray and its application to targeted drug inhalation.
Gomez A
Respir Care; 2002 Dec; 47(12):1419-31; discussion 1431-3. PubMed ID: 12467500
[TBL] [Abstract][Full Text] [Related]
40. Devices for Improved Delivery of Nebulized Pharmaceutical Aerosols to the Lungs.
Longest W; Spence B; Hindle M
J Aerosol Med Pulm Drug Deliv; 2019 Oct; 32(5):317-339. PubMed ID: 31287369
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
